Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status

Acta Oncologica

Volumn 49, Issue 3, 2010, Pages 382-388

  Komosinska, Katarzyna ^a   Kepka, Lucyna ^a   Niwinska, Anna ^a   Pietrzak, Lucyna ^a   Wierzchowski, Marek ^a   Tyc Szczepaniak, Dobromira ^a   Kaczmarczyk, Agnieszka ^b   Bujko, Krzysztof ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Warmia and Masuria Oncology Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ANOREXIA; ARTICLE; BALANCE DISORDER; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CHECKLIST; DYSPEPSIA; FATIGUE; FEMALE; HAIR LOSS; HEADACHE; HEARING LOSS; HUMAN; INSOMNIA; KARNOFSKY PERFORMANCE STATUS; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MOOD DISORDER; NAUSEA; NEUROLOGIC EXAMINATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; SPEECH DISORDER; SYMPTOM; VOMITING; WALKING DIFFICULTY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PALLIATIVE CARE; POLAND; PROSPECTIVE STUDIES; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 77951273337     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903352942     Document Type: Article

References (20)

1. Posner J. Management of central nervous system metastases. Semin Oncol 1977;4:81-91. (Pubitemid 8071003)
2. Zimm S, Wampler GL, Stablein D, Hazna T, Young HF. Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 1981;48:384-394 (Pubitemid 11127382)
3. Sen M, Demiral AS, Cetingoz R, Alanyali H, Akman F, Senturk D, et al. Prognostic factors in lung cancer with brain metastasis. Radiother Oncol 1998; 46:33-38 (Pubitemid 28072856)
4. Kepka L, Cieslak E, Bujko K, Fijuth J, Wierzchowski M. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: The RTOG RPA intra-classes analysis. Acta Oncol 2005;44:389-398 (Pubitemid 41021044)
5. Bezjak A, Adam J, Barton R, Panzarella T, Laperriere N, Wong CS, et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002;38:487-496 (Pubitemid 34185387)
6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751 (Pubitemid 27181303)
7. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents. MacLeod CM, editor. New York: Columbia University Press; 1949. p. 191-205.
8. Lutterbach J, Bartelt S, Stancu E, Guttenberger R. Patients with brain metastases: Hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol 2002;63:339-345 (Pubitemid 34874562)
9. Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roent Rad Ther Nucl Med 1971;3:334-336
10. Van de Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomized trial. Lancet 2005;366:985-990 (Pubitemid 41323034)
11. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective evaluation of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005;30:18-23. (Pubitemid 41021675)
12. Chow E, Fan G, Hadi S, Wong J, Kirou-Mauro A, Filipczak L. Symptom clusters in cancer patients with brain metastases. Clin Oncol (R Coll Radiol) 2008;20:76-82. (Pubitemid 351630192)
13. Steel GG. Basic clinical radiobiology. Hodder Arnold: London; 1999.
14. Waldron D, O'Boyle CA, Kearney M, Moriarty M, Carney D. Quality of life measurement in advanced cancer: Assessing the individual. J Clin Oncol 1999;17:3603-3611 (Pubitemid 29517933)
15. Gelber RD, Larson M, Borgelt BB, Kramer S. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48:1749-53. (Pubitemid 11022876)
16. Chatani M, Matavoshi Y, Masaki N, Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 1994;170:155-161 (Pubitemid 24104528)
17. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006;3.
18. Extermann M, Albrand G, Chen H, Zanetta S, Schonwetter R, Zulian GB, et al. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 2003;21:3214-3219 (Pubitemid 46606252)
19. Chernov MF, Nakaya K, Izawa M, Hayashi M, Usuba Y, Kato K, et al. Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) score. Int J Radiat Oncol Biol Phys 2007;67:1492-1498 (Pubitemid 46467174)
20. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: Who may not benefit? Int J Radiat Oncol Biol Phys 2001; 51:1320-1327 (Pubitemid 33116327)